These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18432989)

  • 1. Measurement of peptide dissociation from MHC class II molecules.
    Chaves FA; Sant AJ
    Curr Protoc Immunol; 2007 May; Chapter 18():18.14.1-18.14.11. PubMed ID: 18432989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
    Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
    J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two structural states of complexes of peptide and class II major histocompatibility complex revealed by photoaffinity-labeled peptides.
    Carrasco-Marín E; Petzold S; Unanue ER
    J Biol Chem; 1999 Oct; 274(44):31333-40. PubMed ID: 10531333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodominance does not result from peptide competition for MHC class II presentation.
    Lo-Man R; Langeveld JP; Martineau P; Hofnung M; Meloen RH; Leclerc C
    J Immunol; 1998 Feb; 160(4):1759-66. PubMed ID: 9469434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of azapeptides as major histocompatibility complex class II protein ligands for T-cell activation.
    Hart M; Beeson C
    J Med Chem; 2001 Oct; 44(22):3700-9. PubMed ID: 11606135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens.
    Crotzer VL; Glosson N; Zhou D; Nishino I; Blum JS
    Immunology; 2010 Nov; 131(3):318-30. PubMed ID: 20518820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of both MHC class I- and class II-restricted antigenic peptides from exogenously added ovalbumin in murine phagosomes.
    Muno D; Kominami E; Mizuochi T
    FEBS Lett; 2000 Jul; 478(1-2):178-82. PubMed ID: 10922492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
    Carstens C; Newman DK; Bohlen H; König A; Koch N
    Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a systems understanding of MHC class I and MHC class II antigen presentation.
    Neefjes J; Jongsma ML; Paul P; Bakke O
    Nat Rev Immunol; 2011 Nov; 11(12):823-36. PubMed ID: 22076556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation of complexes of major histocompatibility class II molecules and known antigenic peptide by metal chelate affinity chromatography.
    Nag B; Mukku PV; Arimilli S; Kendrick T; Deshpande SV; Sharma SD
    J Immunol Methods; 1994 Mar; 169(2):273-85. PubMed ID: 7510762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mhc-guided processing: binding of large antigen fragments.
    Sercarz EE; Maverakis E
    Nat Rev Immunol; 2003 Aug; 3(8):621-9. PubMed ID: 12974477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studying MHC Class II Peptide Loading and Editing In Vitro.
    Kim A; Ishizuka IE; Hartman IZ; Poluektov Y; Narayan K; Sadegh-Nasseri S
    Methods Mol Biol; 2019; 1988():343-355. PubMed ID: 31147951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice.
    Suh CH; Freed JH; Cohen PL
    J Immunol; 2003 Feb; 170(4):2229-35. PubMed ID: 12574397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloned T cells internalize peptide from bound complexes of peptide and purified class II major histocompatibility complex antigen.
    Nag B; Deshpande SV; Sharma SD; Clark BR
    J Biol Chem; 1993 Jul; 268(19):14360-6. PubMed ID: 7686154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M.
    Honey K; Forbush K; Jensen PE; Rudensky AY
    J Immunol; 2004 Apr; 172(7):4142-50. PubMed ID: 15034026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for invariant chain 85-101 (CLIP) binding in the antigen binding site of MHC class II molecules.
    Bangia N; Watts TH
    Int Immunol; 1995 Oct; 7(10):1585-91. PubMed ID: 8562503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular antigen processing and presentation by immature dendritic cells.
    Santambrogio L; Sato AK; Carven GJ; Belyanskaya SL; Strominger JL; Stern LJ
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15056-61. PubMed ID: 10611337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-B Cell Receptor Complexes Associate with Intracellular major histocompatibility complex (MHC) Class II Molecules.
    Barroso M; Tucker H; Drake L; Nichol K; Drake JR
    J Biol Chem; 2015 Nov; 290(45):27101-27112. PubMed ID: 26400081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of T cells by antigenic peptide complexed with isolated chains of major histocompatibility complex class II molecules.
    Nag B; Wada HG; Deshpande SV; Passmore D; Kendrick T; Sharma SD; Clark BR; McConnell HM
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1604-8. PubMed ID: 7679510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.